Skip to main content
NCBI home page
Journal of Medical Toxicology logoLink to Journal of Medical Toxicology
. 2010 Aug 20;6(4):413–419. doi: 10.1007/s13181-010-0110-x

Case Files of the Harvard Medical Toxicology Fellowship at Children’s Hospital Boston: An Insulin Overdose

Aaron Benjamin Skolnik 1,2,✉, Michele Burns Ewald 1
PMCID: PMC3550466  PMID: 20725819

Full Text

The Full Text of this article is available as a PDF (138.1 KB).

References

  • 1.Active Ingredient Search (2010) In: Approved drug products with therapeutic equivalence evaluations (Orange Book). http://www.accessdata.fda.gov/scripts/cder/ob/docs/tempai.cfm. Accessed 12 Jun 2010
  • 2.DeWitt DE, Hirsch IB. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA. 2003;289:2254–2264. doi: 10.1001/jama.289.17.2254. [DOI] [PubMed] [Google Scholar]
  • 3.DeWitt DE, Dugdale DC. Using new insulin strategies in the outpatient treatment of diabetes: clinical applications. JAMA. 2003;289:2265–2269. doi: 10.1001/jama.289.17.2265. [DOI] [PubMed] [Google Scholar]
  • 4.Saudek CD. Novel forms of insulin delivery. Endocrinol Metab Clin North Am. 1997;26:599–610. doi: 10.1016/S0889-8529(05)70269-3. [DOI] [PubMed] [Google Scholar]
  • 5.Lenhard MJ, Reeves GD. Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med. 2001;161:2293–2300. doi: 10.1001/archinte.161.19.2293. [DOI] [PubMed] [Google Scholar]
  • 6.Klonoff DC, Reyes JS. Insulin pump safety meeting: summary report. J Diabetes Sci Technol. 2009;3:396–402. doi: 10.1177/193229680900300224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Rule AM, Drincic A, Galt KA. New technology, new errors: how to prime an upgrade of an insulin infusion pump. Jt Comm J Qual Patient Saf. 2007;33:155–162. doi: 10.1016/s1553-7250(07)33018-3. [DOI] [PubMed] [Google Scholar]
  • 8.Guilhem I, Balkau B, Lecordier F, Malecot JM, Elbadii S, Leguerrier AM, et al. Insulin pump failures are still frequent: a prospective study over 6 years from 2001 to 2007. Diabetologia. 2009;52:2662–2664. doi: 10.1007/s00125-009-1549-7. [DOI] [PubMed] [Google Scholar]
  • 9.Cope JU, Morrison AE, Samuels-Reid J. Adolescent use of insulin and patient-controlled analgesia pump technology: a 10-year food and drug administration retrospective study of adverse events. Pediatrics. 2008;121:1133–1138. doi: 10.1542/peds.2007-1707. [DOI] [PubMed] [Google Scholar]
  • 10.Teutsch SM, Herman WH, Dwyer DM, Lane JM. Mortality among diabetic patients using continuous subcutaneous insulin-infusion pumps. N Engl J Med. 1984;310:361–368. doi: 10.1056/NEJM198402093100606. [DOI] [PubMed] [Google Scholar]
  • 11.Wredling R, Lin PE, Adamson U. Pump “run-away” causing severe hypoglycaemia. Lancet. 1989;2:273. doi: 10.1016/S0140-6736(89)90455-8. [DOI] [PubMed] [Google Scholar]
  • 12.Midthjell K, Kapelrud H, Bjornerud A, Claudi T, Bjorgaas M, Jervell J. Severe or life-threatening hypoglycemia in insulin pump treatment. Diab Care. 1994;17:1235–1236. doi: 10.2337/diacare.17.10.1235. [DOI] [PubMed] [Google Scholar]
  • 13.Tritos NA, Casper K, King G. Museum visit leading to insulin pump malfunction. Ann Intern Med. 1997;126:746. doi: 10.7326/0003-4819-126-9-199705010-00034. [DOI] [PubMed] [Google Scholar]
  • 14.Reiher AE, Gallagher TA, Emanuele MA. Interference at work: a case report of a malfunctioning insulin pump. Endocr. 2009;35:22–24. doi: 10.1007/s12020-008-9122-6. [DOI] [PubMed] [Google Scholar]
  • 15.Mecklenburg RS, Benson EA, Benson JW, Jr, Fredlund PN, Guinn T, Metz RJ, et al. Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients. JAMA. 1984;252:3265–3269. doi: 10.1001/jama.252.23.3265. [DOI] [PubMed] [Google Scholar]
  • 16.Mecklenburg RS, Guinn TS, Sannar CA, Blumenstein BA. Malfunction of continuous subcutaneous insulin infusion systems: a 1-year prospective study of 127 patients. Diab Care. 1986;9:351–355. doi: 10.2337/diacare.9.4.351. [DOI] [PubMed] [Google Scholar]
  • 17.Diabetes Control and Complications Trial Research Group Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: diabetes control and complications trial. J Pediatr. 1994;125:177–188. doi: 10.1016/S0022-3476(94)70190-3. [DOI] [PubMed] [Google Scholar]
  • 18.The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986. doi: 10.1056/NEJM199309303291401. [DOI] [PubMed] [Google Scholar]
  • 19.Kaufman FR, Halvorson M, Miller D, Mackenzie M, Fisher LK, Pitukcheewanont P. Insulin pump therapy in type 1 pediatric patients: now and into the year 2000. Diabetes Metab Res Rev. 1999;15:338–352. doi: 10.1002/(SICI)1520-7560(199909/10)15:5<338::AID-DMRR57>3.0.CO;2-Y. [DOI] [PubMed] [Google Scholar]
  • 20.Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes. Diab Care. 1996;19:324–327. doi: 10.2337/diacare.19.4.324. [DOI] [PubMed] [Google Scholar]
  • 21.Fatourechi MM, Kudva YC, Murad MH, Elamin MB, Tabini CC, Montori VM. Clinical review: hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab. 2009;94:729–740. doi: 10.1210/jc.2008-1415. [DOI] [PubMed] [Google Scholar]
  • 22.Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363:311–320. doi: 10.1056/NEJMoa1002853. [DOI] [PubMed] [Google Scholar]
  • 23.Osipoff JN, Sattar N, Garcia M, Wilson TA. Prime-time hypoglycemia: factitious hypoglycemia during insulin-pump therapy. Pediatrics. 2010;125:1246–1248. doi: 10.1542/peds.2009-1830. [DOI] [PubMed] [Google Scholar]
  • 24.Franklin VL, Bluff S, Ramsay V, Sturrock C, Greene SA, Alexander V. Unexplained hypoglycaemia on a pump. Pediatr Diabetes. 2007;8:391–392. doi: 10.1111/j.1399-5448.2007.00295.x. [DOI] [PubMed] [Google Scholar]
  • 25.Benedict B, Keyes R, Sauls FC. The insulin pump as murder weapon: a case report. Am J Forensic Med Pathol. 2004;25:159–160. doi: 10.1097/01.paf.0000127383.69760.72. [DOI] [PubMed] [Google Scholar]
  • 26.Burns MJ, Levine MD. Diabetic control agents. In: Shannon MW, Borron SW, Burns MJ, editors. Haddad and Winchester’s clinical management of poisoning and drug overdose. 4. Philadelphia: Saunders Elsevier; 2007. pp. 1019–1032. [Google Scholar]
  • 27.Linden CH. Antidiabetic agents. In: Brent J, Wallace KL, Burkhart KK, Phillips SD, Donovan JW, editors. Critical care toxicology: diagnosis and treatment of the critically poisoned patient. 1. Philadelphia: Elsevier Mosby; 2005. pp. 729–740. [Google Scholar]
  • 28.BWH Laboratory Handbook (2009) In: Brigham and Women’s Hospital. http://www.brighamandwomens.org/clinicallabs/Medical/lab.manual.07092009.pdf. Accessed 6 Jul 2010
  • 29.Lebowitz MR, Blumenthal SA. The molar ratio of insulin to C-peptide. An aid to the diagnosis of hypoglycemia due to surreptitious (or inadvertent) insulin administration. Arch Intern Med. 1993;153:650–655. doi: 10.1001/archinte.153.5.650. [DOI] [PubMed] [Google Scholar]
  • 30.Iwase H, Kobayashi M, Nakajima M, Takatori T. The ratio of insulin to C-peptide can be used to make a forensic diagnosis of exogenous insulin overdosage. Forensic Sci Int. 2001;115:123–127. doi: 10.1016/S0379-0738(00)00298-X. [DOI] [PubMed] [Google Scholar]
  • 31.Spiller HA. Management of antidiabetic medications in overdose. Drug Saf. 1998;19:411–424. doi: 10.2165/00002018-199819050-00007. [DOI] [PubMed] [Google Scholar]
  • 32.Seltzer HS. Drug-induced hypoglycemia. A review of 1418 cases. Endocrinol Metab Clin North Am. 1989;18:163–183. [PubMed] [Google Scholar]
  • 33.Chan JC, Cockram CS, Critchley JA. Drug-induced disorders of glucose metabolism. Mechanisms and management. Drug Saf. 1996;15:135–157. doi: 10.2165/00002018-199615020-00005. [DOI] [PubMed] [Google Scholar]
  • 34.Marks V, Teale JD. Drug-induced hypoglycemia. Endocrinol Metab Clin North Am. 1999;28:555–577. doi: 10.1016/S0889-8529(05)70088-8. [DOI] [PubMed] [Google Scholar]
  • 35.Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes. 2005;54:3592–3601. doi: 10.2337/diabetes.54.12.3592. [DOI] [PubMed] [Google Scholar]
  • 36.Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med. 2004;350:2272–2279. doi: 10.1056/NEJMra031354. [DOI] [PubMed] [Google Scholar]
  • 37.Odeh M, Oliven A, Bassan H. Transient atrial fibrillation precipitated by hypoglycemia. Ann Emerg Med. 1990;19:565–567. doi: 10.1016/S0196-0644(05)82191-2. [DOI] [PubMed] [Google Scholar]
  • 38.Chelliah YR. Ventricular arrhythmias associated with hypoglycaemia. Anaesth Intensive Care. 2000;28:698–700. doi: 10.1177/0310057X0002800617. [DOI] [PubMed] [Google Scholar]
  • 39.Marques JL, George E, Peacey SR, Harris ND, Macdonald IA, Cochrane T, et al. Altered ventricular repolarization during hypoglycaemia in patients with diabetes. Diabet Med. 1997;14:648–654. doi: 10.1002/(SICI)1096-9136(199708)14:8<648::AID-DIA418>3.0.CO;2-1. [DOI] [PubMed] [Google Scholar]
  • 40.Lindstrom T, Jorfeldt L, Tegler L, Arnqvist HJ. Hypoglycaemia and cardiac arrhythmias in patients with type 2 diabetes mellitus. Diabet Med. 1992;9:536–541. doi: 10.1111/j.1464-5491.1992.tb01834.x. [DOI] [PubMed] [Google Scholar]
  • 41.Tanenberg RJ, Newton CA, Drake AJ. Confirmation of hypoglycemia in the “dead-in-bed” syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr Pract. 2010;16:244–248. doi: 10.4158/EP09260.CR. [DOI] [PubMed] [Google Scholar]
  • 42.Passias TC, Meneilly GS, Mekjavic IB. Effect of hypoglycemia on thermoregulatory responses. J Appl Physiol. 1996;80:1021–1032. doi: 10.1152/jappl.1996.80.3.1021. [DOI] [PubMed] [Google Scholar]
  • 43.Uchida D, Ohigashi S, Hikita S, Kitamura N, Motoyoshi M, Tatsuno I. Acute pulmonary edema caused by hypoglycemia due to insulin overdose. Intern Med. 2004;43:1056–1059. doi: 10.2169/internalmedicine.43.1056. [DOI] [PubMed] [Google Scholar]
  • 44.Matsumura M, Nakashima A, Tofuku Y. Electrolyte disorders following massive insulin overdose in a patient with type 2 diabetes. Intern Med. 2000;39:55–57. doi: 10.2169/internalmedicine.39.55. [DOI] [PubMed] [Google Scholar]
  • 45.Bosse GM, et al. Antidiabetics and hypoglycemics. In: Flomenbaum NE, Goldfrank LR, Hoffman RS, et al., editors. Goldfrank’s toxicologic emergencies. 8. New York: McGraw-Hill; 2006. pp. 749–760. [Google Scholar]
  • 46.Stewart WJ, McSweeney SM, Kellett MA, Faxon DP, Ryan TJ. Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization. Circulation. 1984;70:788–792. doi: 10.1161/01.cir.70.5.788. [DOI] [PubMed] [Google Scholar]
  • 47.Gupta SK, Veith FJ, Ascer E, Wengerter KR, Franco C, Amar D, et al. Anaphylactoid reactions to protamine: an often lethal complication in insulin-dependent diabetic patients undergoing vascular surgery. J Vasc Surg. 1989;9:342–350. doi: 10.1067/mva.1989.vs0090342. [DOI] [PubMed] [Google Scholar]
  • 48.Hulshof MM, Faber WR, Kniestedt WF, Boeree MJ, Kreek P. Granulomatous hypersensitivity to protamine as a complication of insulin therapy. Br J Dermatol. 1992;127:286–288. doi: 10.1111/j.1365-2133.1992.tb00130.x. [DOI] [PubMed] [Google Scholar]
  • 49.Dykewicz MS, Kim HW, Orfan N, Yoo TJ, Lieberman P. Immunologic analysis of anaphylaxis to protamine component in neutral protamine Hagedorn human insulin. J Allergy Clin Immunol. 1994;93:117–125. doi: 10.1016/0091-6749(94)90240-2. [DOI] [PubMed] [Google Scholar]
  • 50.Rasanen L, Tuomi ML, Lahtela J, Knip M. Hypersensitization to protamine-containing insulin. Duodecim. 1995;111:914–918. [PubMed] [Google Scholar]
  • 51.Blanco C, Castillo R, Quiralte J, Delgado J, Garcia I, de Pablos P, et al. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin. Allergy. 1996;51:421–424. [PubMed] [Google Scholar]
  • 52.Petays T, Kiistala R, Makinen-Kiljunen S. Immediate protamine sulphate allergy in an insulin-treated diabetic patient. Duodecim. 1999;115:517–520. [PubMed] [Google Scholar]
  • 53.Bollinger ME, Hamilton RG, Wood RA. Protamine allergy as a complication of insulin hypersensitivity: a case report. J Allergy Clin Immunol. 1999;104:462–465. doi: 10.1016/S0091-6749(99)70394-5. [DOI] [PubMed] [Google Scholar]
  • 54.Raap U, Liekenbrocker T, Kapp A, Wedi B. Delayed-type hypersensitivity to protamine as a complication of insulin therapy. Contact Dermat. 2005;53:57–58. doi: 10.1111/j.0105-1873.2005.00456d.x. [DOI] [PubMed] [Google Scholar]
  • 55.Adler PM. Serum glucose changes after administration of 50% dextrose solution: pre- and in-hospital calculations. Am J Emerg Med. 1986;4:504–506. doi: 10.1016/S0735-6757(86)80004-3. [DOI] [PubMed] [Google Scholar]
  • 56.Palatnick W, Meatherall RC, Tenenbein M. Clinical spectrum of sulfonylurea overdose and experience with diazoxide therapy. Arch Intern Med. 1991;151:1859–1862. doi: 10.1001/archinte.151.9.1859. [DOI] [PubMed] [Google Scholar]
  • 57.Campbell IW, Ratcliffe JG. Suicidal insulin overdose managed by excision of insulin injection site. Br Med J. 1982;285:408–409. doi: 10.1136/bmj.285.6339.408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.McIntyre AS, Woolf VJ, Burnham WR. Local excision of subcutaneous fat in the management of insulin overdose. Br J Surg. 1986;73:538. doi: 10.1002/bjs.1800730707. [DOI] [PubMed] [Google Scholar]
  • 59.Levine DF, Bulstrode C. Managing suicidal insulin overdose. Br Med J. 1982;285:974–975. doi: 10.1136/bmj.285.6346.974-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Arem R, Zoghbi W. Insulin overdose in eight patients: insulin pharmacokinetics and review of the literature. Medicine. 1985;64:323–332. doi: 10.1097/00005792-198509000-00004. [DOI] [PubMed] [Google Scholar]
  • 61.Brvar M, Mozina M, Bunc M. Prolonged hypoglycaemia after insulin lispro overdose. Eur J Emerg Med. 2005;12:234–235. doi: 10.1097/00063110-200510000-00007. [DOI] [PubMed] [Google Scholar]
  • 62.Fromont I, Benhaim D, Ottomani A, Valero R, Molines L, Vialettes B. Prolonged glucose requirements after intentional glargine and aspart overdose. Diabetes Metab. 2007;33:390–392. doi: 10.1016/j.diabet.2007.05.002. [DOI] [PubMed] [Google Scholar]
  • 63.Fuller ET, Miller MA, Kaylor DW, Janke C. Lantus overdose: case presentation and management options. J Emerg Med. 2009;36:26–29. doi: 10.1016/j.jemermed.2007.02.038. [DOI] [PubMed] [Google Scholar]
  • 64.Robotic Pancreas: One Man’s Quest to Put Millions of Diabetics on Autopilot (2010) In: Wired Magazine. http://www.wired.com/magazine/2010/04/ff_pancreas/. Accessed 1 Aug 2010
  • 65.Insulin Comparison Chart (2007) In: University of Kentucky Chandler Medical Center. http://www.hosp.uky.edu/pharmacy/formulary/formtools/InsulinComparisonChart.pdf. Accessed 30 May 2010
  • 66.Insulin: Compare Common Options for Insulin Therapy (2010) In: MayoClinic.com. http://www.mayoclinic.com/health/insulin/da00091. Accessed 12 Jun 2010

Articles from Journal of Medical Toxicology are provided here courtesy of Springer

RESOURCES